Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
Go back to Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.82 +0.28 (7.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.54 | 52 Week High | $16.89 | |||
| Open | $3.60 | 52 Week Low | $7.35 | |||
| Day High | $3.91 | P/E | N/A | |||
| Day Low | $3.57 | EPS | $-2.35 | |||
| Volume | 2,522,941 | |||||
